Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

BTMD - Biote Corp Stock Price, Fair Value and News

$3.77+0.70 (+22.80%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

BTMD Price Action

Last 7 days

-11.5%

Last 30 days

-19.1%

Last 90 days

-40.8%

Trailing 12 Months

-39.3%

BTMD Stock Price

Mar'24Jun'24Sep'24Dec'243456789
$3.77

BTMD RSI Chart

JunJulAugSepOctNovDec2025FebMar20304050607080

BTMD Valuation

Market Cap

129.2M

Price/Earnings (Trailing)

-54.35

Price/Sales (Trailing)

0.66

EV/EBITDA

13.53

Price/Free Cashflow

3.33

BTMD Price/Sales (Trailing)

2023202420250.20.40.60.811.21.4

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BTMD Fundamentals

BTMD Revenue

Revenue (TTM)

197.2M

Rev. Growth (Yr)

9.04%

Rev. Growth (Qtr)

-3.02%

20202021202220232024100M120M140M160M180M200M

BTMD Earnings

Earnings (TTM)

-2.4M

Earnings Growth (Yr)

-84.15%

Earnings Growth (Qtr)

-71.83%

20202021202220232024-30M-20M-10M010M20M30M

BTMD Profitability

Operating Margin

75.24%

EBT Margin

0.52%

Return on Equity

2.33%

Return on Assets

-1.94%

Free Cashflow Yield

30.04%

BTMD Investor Care

Shares Dilution (1Y)

33.30%

Diluted EPS (TTM)

0.14

Revenue Breakdown

As of: Sep 30, 2024
20222023202435M40M45M50M
Product Revenue
ProductValuePercent
GeographyValuePercent
TotalValuePercent

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
20202021202220232024100M120M140M160M180M200M
Net sales
YearQ1Q2Q3Q4
2024187.3M187.2M193.1M197.2M
2023172.7M180.6M184.1M185.4M
2022145.0M151.6M158.0M165.0M
2021122.3M128.0M133.7M139.4M
2020000116.6M
2019000110.0M
Get all data in R, Python etc through our Historical Stock Data APIs

About Biote Corp

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irvine, Texas.
 CEO
 WEBSITEhttps://biote.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES186

Biote Corp Frequently Asked Questions

What is the ticker symbol for Biote Corp? What does BTMD stand for in stocks?

BTMD is the stock ticker symbol of Biote Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Biote Corp (BTMD)?

As of Fri Mar 14 2025, market cap of Biote Corp is 129.2 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BTMD stock?

You can check BTMD's fair value in chart for subscribers.

Is Biote Corp a good stock to buy?

The fair value guage provides a quick view whether BTMD is over valued or under valued. Whether Biote Corp is cheap or expensive depends on the assumptions which impact Biote Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BTMD.

What is Biote Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Mar 14 2025, BTMD's PE ratio (Price to Earnings) is -54.35 and Price to Sales (PS) ratio is 0.66. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BTMD PE ratio will change depending on the future growth rate expectations of investors.